ArticleDrug design, development and therapy2014

Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.

Can Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.